Using Inhibitors of Prenylation to Block Localization and Transforming Activity

Methods in Enzymology

Volumn 407, Issue , 2006, Pages 575-597

  Berzat, Anastacia C ^a   Brady, Donita C ^a   Fiordalisi, James J ^a   Cox, Adrienne D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; 3 BENZYL 7 CYANO 2,3,4,5 TETRAHYDRO 1 (1H IMIDAZOL 4 YLMETHYL) 4 (2 THIENYLSULFONYL) 1H 1,4 BENZODIAZEPINE; AGAR; ALX 290 005; FTI 2153; G 242; GERANYLGERANYLTRANSFERASE 1 INHIBITOR; GGTI 2166; GGTI 2417; GGTI 298; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; L 7287; L 774832; L 778123; LONAFARNIB; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TIPIFARNIB; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

CLINICAL TRIAL; COLONY FORMING UNIT; ENZYME LOCALIZATION; HUMAN; IMMUNOPRECIPITATION; NONHUMAN; PRENYLATION; PRIORITY JOURNAL; REVIEW;

EID: 33744524839     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)07046-1     Document Type: Review

References (22)

1. Berzat A.C., Buss J.E., Chenette E.J., Weinbaum C.A., Shutes A., Der C.J., Minden A., and Cox A.D. Transforming activity of the Rho family GTPase, Wrch-1, a Wnt-regulated Cdc42 homolog, is dependent on a novel carboxyl-terminal palmitoylation motif. J. Biol. Chem. 280 (2005) 33055-33065
2. Casey P.J., and Seabra M.C. Protein prenyltransferases. J. Biol. Chem. 271 (1996) 5289-5292
3. Chuang T.H., Xu X., Knaus U.G., Hart M.J., and Bokoch G.M. GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein. J. Biol. Chem. 268 (1993) 775-778
4. Cox A.D., and Der C.J. Farnesyltransferase inhibitors and cancer treatment: Targeting simply Ras?. Biochim. Biophys. Acta 1333 (1997) F51-F71
5. Cox A.D., Solski P.A., Jordan J.D., and Der C.J. Analysis of Ras protein expression in mammalian cells. Methods Enzymol. 255 (1995) 195-220
6. Fiordalisi J.J., Johnson II R.L., Ulku A.S., Der C.J., and Cox A.D. Mammalian expression vectors for Ras family proteins: Generation and use of expression constructs to analyze Ras family function. Methods Enzymol. 332 (2001) 3-36
7. Fukumoto Y., Kaibuchi K., Hori Y., Fujioka H., Araki S., Ueda T., Kikuchi A., and Takai Y. Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins. Oncogene 5 (1990) 1321-1328
8. Gana-Weisz M., Haklai R., Marciano D., Egozi Y., Ben-Baruch G., and Kloog Y. The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation. Biochem. Biophys. Res. Commun. 239 (1997) 900-904
9. Hart M.J., Maru Y., Leonard D., Witte O.N., Evans T., and Cerione R.A. A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science 258 (1992) 812-815
10. Joyce P.L., and Cox A.D. Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane ruffling. Cancer Res. 63 (2003) 7959-7967
11. Keller P.K., Fiordalisi J.J., Berzat A.C., and Cox A.D. Visual monitoring of post-translational lipid modifications using EGFP-GTPase probes in live cells. Methods 37 (2005) 131-137
12. Khosravi-Far R., Solski P.A., Clark G.J., Kinch M.S., and Der C.J. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15 (1995) 6443-6453
13. Leonard D.A., and Cerione R.A. Solubilization of Cdc42Hs from membranes by Rho-GDP dissociation inhibitor. Methods Enzymol. 256 (1995) 98-105
14. Marom M., Haklai R., Ben-Baruch G., Marciano D., Egozi Y., and Kloog Y. Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid. J. Biol. Chem. 270 (1995) 22263-22270
15. Michaelson D., Silletti J., Murphy G., D'Eustachio P., Rush M., and Philips M.R. Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152 (2001) 111-126
16. Qiu R.G., Chen J., Kirn D., McCormick F., and Symons M. An essential role for Rac in Ras transformation. Nature 374 (1995) 457-459
17. Qiu R.G., Chen J., McCormick F., and Symons M. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92 (1995) 11781-11785
18. Rotblat B., Niv H., Andre S., Kaltner H., Gabius H.J., and Kloog Y. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res. 64 (2004) 3112-3118
19. Sebti S.M., and Der C.J. Opinion: Searching for the elusive targets of farnesyltransferase inhibitors. Nat. Rev. Cancer 3 (2003) 945-951
20. Sebti S.M., and Hamilton A.D. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies. Oncogene 19 (2000) 6584-6593
21. Tao W., Pennica D., Xu L., Kalejta R.F., and Levine A.J. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev. 15 (2001) 1796-1807
22. Whyte D.B., Kirschmeier P., Hockenberry T.N., Nunez-Oliva I., James L., Catino J.J., Bishop W.R., and Pai J.K. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J. Biol. Chem. 272 (1997) 14459-14464